Bupropion Hydrochloride Tablet
Product Images NDC 70518-4448

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 70518-4448). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is information regarding Bupropion HCI Tablet, manufactured by BluePoint Labs in India. It is an Extended-Release (XL) tablet with a strength of 150 mg. The medication should be stored at a temperature between 20-25°C (68-77°F) with excursions permitted to 15-30°C (59-86°F). The warning advises not to use in combination with Zyban or any other medicines containing Bupropion HCI. The usual dosage instructions can be found in the insert. The product has been repackaged by RemedyRepack Inc.*
FDA Label Image

Bupropion-structure.jpg (Bupropion Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.